Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.
(2013) In International Journal of Gynecological Cancer 23(9). p.1642-1646- Abstract
- The superiority of positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) over computed tomography and magnetic resonance imaging in detecting recurrent cervical cancer and determining the extent of the disease has been demonstrated in several clinical trials. However, there is a lack of data concerning the clinical impact of the extra findings. We report here a prospective clinical study aimed at investigating the clinical impact of FDG-PET findings on the treatment plans in recurrent cervical cancer.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4179924
- author
- Bjurberg, Maria LU and Brun, Eva LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- International Journal of Gynecological Cancer
- volume
- 23
- issue
- 9
- pages
- 1642 - 1646
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:24177254
- wos:000330374300016
- scopus:84888391720
- pmid:24177254
- ISSN
- 1048-891X
- DOI
- 10.1097/IGC.0b013e3182a50537
- language
- English
- LU publication?
- yes
- id
- 07707177-7883-41f9-8e14-8aef67ad4a14 (old id 4179924)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24177254?dopt=Abstract
- date added to LUP
- 2016-04-01 11:11:45
- date last changed
- 2022-11-02 02:06:09
@article{07707177-7883-41f9-8e14-8aef67ad4a14, abstract = {{The superiority of positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) over computed tomography and magnetic resonance imaging in detecting recurrent cervical cancer and determining the extent of the disease has been demonstrated in several clinical trials. However, there is a lack of data concerning the clinical impact of the extra findings. We report here a prospective clinical study aimed at investigating the clinical impact of FDG-PET findings on the treatment plans in recurrent cervical cancer.}}, author = {{Bjurberg, Maria and Brun, Eva}}, issn = {{1048-891X}}, language = {{eng}}, number = {{9}}, pages = {{1642--1646}}, publisher = {{BMJ Publishing Group}}, series = {{International Journal of Gynecological Cancer}}, title = {{Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.}}, url = {{http://dx.doi.org/10.1097/IGC.0b013e3182a50537}}, doi = {{10.1097/IGC.0b013e3182a50537}}, volume = {{23}}, year = {{2013}}, }